Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends

SG&A Expenses: Dr. Reddy's vs. Walgreens Boots

__timestampDr. Reddy's Laboratories LimitedWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20143878300000017992000000
Thursday, January 1, 20154258500000022400000000
Friday, January 1, 20164570200000023910000000
Sunday, January 1, 20174637200000023813000000
Monday, January 1, 20184691000000024694000000
Tuesday, January 1, 20194889000000023557000000
Wednesday, January 1, 20205012900000025436000000
Friday, January 1, 20215455900000024586000000
Saturday, January 1, 20226208100000027295000000
Sunday, January 1, 202310593100000034205000000
Monday, January 1, 20247720100000028113000000
Loading chart...

Unveiling the hidden dimensions of data

SG&A Expense Trends: A Comparative Analysis

In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding the financial dynamics of key players is crucial. Dr. Reddy's Laboratories Limited and Walgreens Boots Alliance, Inc. have been pivotal in their respective industries. Over the past decade, Dr. Reddy's has seen a significant increase in its Selling, General, and Administrative (SG&A) expenses, peaking in 2023 with a staggering 173% rise from 2014. This surge reflects the company's aggressive expansion and strategic investments. In contrast, Walgreens Boots Alliance has maintained a more stable trajectory, with a modest 43% increase in SG&A expenses over the same period. This stability underscores Walgreens' focus on operational efficiency amidst a challenging retail environment. As we look to the future, these trends offer valuable insights into the strategic priorities and market positioning of these industry giants.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025